Dan Shoenholz quoted in S&P Global Market Intelligence
In “Healthcare's inefficiencies make sector appealing to private equity,” S&P Global Market Intelligence highlights that the appetite for deal activity is set to continue as players look to capitalize on inefficiencies in the U.S. market.
EY-Parthenon Managing Director and Co-head of Healthcare Dan Shoenholz weighed in, noting that deal activity in 2018 will likely stay at around the same pace seen in 2017.
"I might say that there are fewer assets of quality. However, the appetite is really hungry," he said. He explained that part of that demand has come from the arrival of new funds which catalyze M&A activity. "If PE legitimately lands their fair share of [corporate asset sales] we could see a push to another high.”